Guilin Sanjin(SZ:002275)2025-06-25 16:14Inventory Management - The company has upgraded its inventory management system, utilizing a BI intelligent analysis system and a professional data analysis team to balance market demand dynamics and cost control [1] - The overall inventory level has significantly decreased compared to the same period last year, maintaining a healthy inventory cycle of 1.5 to 2 months [1] Product Growth Potential - The company’s second and third-line products show a positive growth trend, with the Gejie Dingchuan capsule expected to maintain last year's growth rate, although future growth may slow as the scale expands [1] - The Xuanyunning series has surpassed 100 million yuan in sales in 2021, aiming for double-digit growth this year [1] - Other products like Shuyanquing spray and Compound Cold Granules are also expected to maintain high growth rates [1] Hospital Promotion Progress - The Sanjin Granules, a key product for the company, have shown good sales growth but still require time to significantly contribute to overall sales due to a small base [2] Dividend Policy - The company has consistently implemented a cash dividend policy, proposing a cash dividend of 3.5 yuan per 10 shares for 2024, totaling 206 million yuan [2] - The dividend policy is expected to remain stable unless there are special funding needs [2]